Ani pharmaceuticals reports fourth quarter and full year 2020 results; company positioned for sustainable future growth

Baudette, minn.--(business wire)--ani pharmaceuticals, inc. (“ani” or the “company”) (nasdaq: anip) today announced business highlights and financial results for the three and 12 months ended december 31, 2020. corporate strategy the company's strategy for sustainable future growth is based on four key pillars: build a successful cortrophin franchise; strengthen the generics business by enhancing development capabilities and increased focus on niche opportunities. the acquisition of novitium ph
ANIP Ratings Summary
ANIP Quant Ranking